Author: <span>Mesothelioma News</span>

VA Hospital in MA Performs First Successful Heated Chemotherapy Bath for Mesothelioma Patient

Dr. Lebenthal had been trying to get approval within the VA system for over 3 years, and was very pleased when he got the green light to perform the heated chemo bath. At that point, notes the spokesperson, Dr. Lebenthal had to wait for the right patie…

Woman diagnosed with mesothelioma after working near Expo 88 site

A woman who developed asbestos-related cancer after working next to Brisbane’s famous Expo 88 site has warned the risks of asbestos exposure are still being ignored. Tonya Fenton was working in South Brisbane in 1985 when large parts of the suburb were…

Hot Wampa, a Star Wars and science fiction podcast set up by three…

Three men who became friends at Ely College some years ago are fusing their passion for sci-fi, Star Wars and local news for a heart-warming reason. Dave Marrs, Mark Daws and Paul Cowley got together in February this year to start Hot Wampa, a podcast …

Three Stocks Fall on Monday but Hedge Fund Data Suggests You Might…

Shares of Verastem Inc , Huntsman Corporation , and TrovaGene Inc are among the top losers today as the firms’ share prices have declined by 65%, 24%, and 8%, respectively. Verastem shares dropped on the back of news that the Phase 2 study of its VS-60…

UPDATE 2-Verastem stops cancer therapy development; shares plunge

Verastem Inc said it would wind down studies testing VS-6063, its lead therapy in development, to treat mesothelioma cancer, raising questions about the therapy’s potential to treat other forms of cancers. The company’s shares plunged as much as 63.7 p…

Verastem stops mid-stage VS-6063 mesothelioma study due to lack of efficacy; shares off 54% premarket

Thinly traded micro cap Verastem slumps 54% in premarket trading on robust volume in response to its announcement that has terminated its Phase 2 clinical trial of lead product candidate VS-6063 in mesothelioma after an interim analysis failed to ident…

Aduro Biotech Announces Phase 1b Mesothelioma Trial Featured in Spotlight Poster at ESMO/ECC

Aduro Biotech, Inc. today announced the presentation of updated, interim safety and efficacy data from an ongoing Phase 1b clinical trial of its novel immunotherapy, CRS-207, in combination with standard of care chemotherapy in patients with unresectab…

Former Letcher County teacher’s lawsuit says his cancer was caused by asbestos in school

A former teacher has sued Letcher County Schools and various members of the district saying asbestos exposure caused his cancer. Roger Hall was diagnosed with Mesothelioma, a rare form of cancer, about one year ago.

New study provides key insights into aspirin’s disease-fighting abilities

A research team that includes a Rutgers professor has found that the main ingredient in aspirin targets the activities of an inflammatory protein associated with a wide variety of diseases. The discovery offers hope for the development of more powerful…

Metal Recycling Company that Violated Asbestos & Mercury Regulations Fined

In August, the Massachusetts Department of Environmental Protection announced that a metal recycling business in the state has been assessed over $35,000 in penalties for violating mercury and asbestos regulations. MassDEP had inspected the recycling p…

SELLAS Life Sciences Expands Board Of Directors As It Advances…

The Company’s WT1 cancer vaccine has shown increased survival compared to historical controls in patients with acute myeloid leukemia ; and has also shown encouraging early data in mesothelioma. SELLAS will initiate further studies across at least two …